BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18693004)

  • 41. [Surfactant protein A gene polymorphisms in chronic obstructive pulmonary disease].
    Xie JG; Xu YJ; Zhang ZX; Ni W; Chen SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):91-3. PubMed ID: 15696492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms.
    Ishii T; Wakabayashi R; Kurosaki H; Gemma A; Kida K
    J Hum Genet; 2011 Jan; 56(1):41-6. PubMed ID: 20981038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
    Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients.
    Sainz J; Pérez E; Gómez-Lopera S; López-Fernández E; Moratalla L; Oyonarte S; Jurado M
    Cytokine; 2008 Mar; 41(3):268-78. PubMed ID: 18191407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of CD40 -1C/T polymorphism in the 5'-untranslated region and chronic obstructive pulmonary disease.
    Liu Y; Liang WB; Gao LB; Wang YY; Zhang L
    Clin Chim Acta; 2009 Oct; 408(1-2):56-9. PubMed ID: 19622350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.
    Chappell S; Daly L; Morgan K; Guetta Baranes T; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra P; Miniati M; Monti S; O'Connor CM; Kalsheker N
    Hum Mutat; 2006 Jan; 27(1):103-9. PubMed ID: 16278826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
    Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
    Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
    Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).
    Celedón JC; Lange C; Raby BA; Litonjua AA; Palmer LJ; DeMeo DL; Reilly JJ; Kwiatkowski DJ; Chapman HA; Laird N; Sylvia JS; Hernandez M; Speizer FE; Weiss ST; Silverman EK
    Hum Mol Genet; 2004 Aug; 13(15):1649-56. PubMed ID: 15175276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease.
    Gupta J; Bhadoria DP; Lal MK; Kukreti R; Chattopadhaya D; Gupta VK; Dabur R; Yadav V; Chhillar AK; Sharma GL
    Clin Biochem; 2005 May; 38(5):489-91. PubMed ID: 15820782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity.
    Sata M; Takabatake N; Inoue S; Shibata Y; Abe S; Machiya J; Wada T; Ji G; Kido T; Matsuura T; Muramatsu MA; Kubota I
    Respirology; 2007 Jan; 12(1):34-41. PubMed ID: 17207023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.
    Baran W; Szepietowski JC; Mazur G; Baran E
    Acta Derm Venereol; 2008; 88(2):113-6. PubMed ID: 18311435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COX2 and p53 risk-alleles coexist in COPD.
    Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
    Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy.
    Moraes MO; Pacheco AG; Schonkeren JJ; Vanderborght PR; Nery JA; Santos AR; Moraes ME; Moraes JR; Ottenhoff TH; Sampaio EP; Huizinga TW; Sarno EN
    Genes Immun; 2004 Nov; 5(7):592-5. PubMed ID: 15306847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transforming growth factor-beta1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis.
    Panoulas VF; Douglas KM; Smith JP; Stavropoulos-Kalinoglou A; Metsios GS; Nightingale P; Kitas GD
    Rheumatology (Oxford); 2009 Feb; 48(2):113-8. PubMed ID: 19106168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
    Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
    Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
    Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
    Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty.
    Gordon A; Kiss-Toth E; Stockley I; Eastell R; Wilkinson JM
    Arthritis Rheum; 2008 Oct; 58(10):3157-65. PubMed ID: 18821666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.